4th Quarter - Report

TODD STRATEGY GROUP for ALEXION PHARMACEUTICALS, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

340B Program. Home Infusion for Part B Products. H.R.830 - HELP Copays Act. Medicare Reimbursement for New Technologies.

LobbyistCovered position, as disclosed
ERIC BERGREN Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
KATHERINE FLEMING COTTON Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
PAUL EDATTEL Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
TED LEHMAN Chief of Staff, Senator Tillis; Senate Judiciary Committee-Counsel, then Chief Counsel for Nominations and Senior Counsel; Senate Judiciary Committee-Staff Assistant and Legislative Assistant
KIMBERLY LINTHICUM Legislative Director, Representative Bob Franks; Legislative Correspondent, Representative Charles Taylor; Legislative Correspondent, Representative Bill Martini
JEFF LUCAS Health Policy Advisor, Senator Bill Cassidy; Legislative Assistant/Sr. Legislative Assistant/Legislative Correspondent, Representative Larry Bucshon
TAYLOR SEXTON Advisor to the Assistant Secretary for Preparedness & Response, HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael Burgess
DANIEL M TODD Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 830 (118th)

Health Issues HCR

General issues related to rare disease and orphan drugs. Diagnostics for patients with rare disease. Multi-Cancer Early Detection. H.R.5547/S.476 - Maintaining Investments in New Innovation (MINI) Act. H.R.5539/S.3131 - ORPHAN Cures Act.

LobbyistCovered position, as disclosed
ERIC BERGREN —
KATHERINE FLEMING COTTON —
PAUL EDATTEL —
TED LEHMAN —
KIMBERLY LINTHICUM —
JEFF LUCAS —
TAYLOR SEXTON —
DANIEL M TODD —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5539 (118th), H.R. 5547 (118th), S. 476 (118th), S. 3131 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.